Reading Time: 2 minutes
Sartorius is one of the most exciting German beneficiaries of the biotech AI revolution for me, as the next bottleneck in biotechnology could shift from the computer to the laboratory. A recent experiment by Anthropic illustrates the dimension. Around 950 Claude agents analyzed more than 200,000 enzyme sequences in just 21 hours and identified about 3,500 potentially interesting systems. AI can thus generate enormous amounts of new hypotheses in a very short time. However, these candidates must then be tested in reality. This is where Sartorius...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
